JPH0219119B2 - - Google Patents
Info
- Publication number
- JPH0219119B2 JPH0219119B2 JP57057416A JP5741682A JPH0219119B2 JP H0219119 B2 JPH0219119 B2 JP H0219119B2 JP 57057416 A JP57057416 A JP 57057416A JP 5741682 A JP5741682 A JP 5741682A JP H0219119 B2 JPH0219119 B2 JP H0219119B2
- Authority
- JP
- Japan
- Prior art keywords
- butanol
- amoxicillin
- slurry
- spray
- spray drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/04—Preparation
- C07D499/14—Preparation of salts
- C07D499/16—Preparation of salts of alkali or alkaline earth metals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Description
本発明は水とt−ブタノールの混合液中のナト
リウムアモキシシリンスラリーを噴霧乾燥するこ
とによる固体ナトリウムアモキシシリンの製法に
関する。
固体ナトリウムアモキシシリンは沈澱によつて
製造(英国特許第1241844号および第1286199号の
とおり)されているが、工業的規模においてはト
リエチルアミン又はナトリウム2−エチルヘキサ
ノエイトの様な残留試薬又は過剰の残留溶媒によ
つておこる汚染のため生成物はよくないことがわ
かつている。固体ナトリウムアモキシシリンはま
た凍結乾燥によつて製造(英国特許第1527557号
と第1543317号のとおり)されているが、工業的
使用の必要量を製造するには極めて高価な装置を
要する。更に必要な非常な低温には長時間を必要
とし所定の装置からの生産量は減少する。
本発明の目的は残留試薬又は残留溶媒によつて
おこる汚染のない固体ナトリウムアモキシシリン
を所望の粒子の大きさにて安価且つ短時間に取得
する方法を提供することにある。
本発明の方法はt−ブタノール水溶液中のナト
リウムアモキシシリンスラリーを噴霧乾燥装置で
噴霧乾燥させることからなる。
本発明方法に用いる噴霧乾燥装置は公知の適宜
のものでよく、その形式等は特に限定されない。
噴霧乾燥装置は熱風中にノズルを通じ被乾燥物含
有流体を噴霧分散させるものでありノズルの形式
としては流体を加圧して噴出させる圧力型と高速
回転円盤上に供給して遠心力で飛散させる回転型
があるが、いづれも用いうる。
尚本発明では流体成分が可燃性であるため熱風
としては窒素等を用い酸素濃度を安全濃度にする
ことが望ましい。
本発明の実施例で用いた噴霧乾燥装置は密封サ
イクル式の噴霧乾燥装置である。第1図はその一
例を示す概略図である。この装置は主として乾燥
室1、生成物サイクロン2、排気フアン3、コン
デンサー/スクラバー4、窒素フアン、熱交換機
5、ノズル6及び供給ポンプよりなる。
この装置をサイクロン生成物を排出しながら同
時に運転するよう設定した。先ず窒素を導入して
酸素濃度を安全濃度以下に低下させN2導入温度、
ガス流速、コンデンサー温度等を調節した。次い
で水性t−ブタノールのナトリウムアモキシシリ
ンスラリー8をノズル6から乾燥室内に噴射し
た。乾燥生成物とガスを底部からサイクロンに送
り分離した。
次表に実験結果を示す。次表の結果からt−ブ
タノール水溶液を用いたスラリーの噴霧乾燥がす
ぐれた効果を示すことがわかる。尚入口温度7は
約180℃がまた出口温度9は約120℃が好ましい。
後者は冷却用N210によつて調節しうる。またt
−ブタノール水溶液は水3.6当たりt−ブタノ
ール約1.5を含むものが好ましい。
The present invention relates to a process for making solid sodium amoxicillin by spray drying a slurry of sodium amoxicillin in a mixture of water and t-butanol. Solid sodium amoxicillin is produced by precipitation (as in British Patents Nos. 1241844 and 1286199), but on an industrial scale residual reagents such as triethylamine or sodium 2-ethylhexanoate or excess residual It has been found that the product is poor due to contamination caused by the solvent. Solid sodium amoxicillin has also been produced by freeze-drying (as in British Patents Nos. 1,527,557 and 1,543,317), but this requires very expensive equipment to produce the quantities required for industrial use. Furthermore, the extremely low temperatures required require long periods of time and reduce yields from a given device. An object of the present invention is to provide a method for obtaining solid sodium amoxicillin in a desired particle size at low cost and in a short time without contamination caused by residual reagents or residual solvents. The method of the invention consists of spray drying a slurry of sodium amoxicillin in aqueous t-butanol in a spray dryer. The spray drying device used in the method of the present invention may be any known suitable device, and its type is not particularly limited.
Spray drying equipment sprays and disperses the fluid containing the material to be dried through a nozzle in hot air.The nozzle types include the pressure type, which pressurizes the fluid and sprays it out, and the rotation type, which supplies the fluid onto a high-speed rotating disk and scatters it using centrifugal force. There are different types, but you can use any of them. In the present invention, since the fluid components are flammable, it is desirable to use nitrogen or the like as the hot air to keep the oxygen concentration at a safe concentration. The spray drying apparatus used in the examples of the present invention is a closed cycle type spray drying apparatus. FIG. 1 is a schematic diagram showing an example thereof. The apparatus mainly consists of a drying chamber 1, a product cyclone 2, an exhaust fan 3, a condenser/scrubber 4, a nitrogen fan, a heat exchanger 5, a nozzle 6 and a feed pump. The apparatus was set up to run simultaneously while discharging cyclone products. First, nitrogen is introduced to reduce the oxygen concentration below the safe concentration, and the N2 introduction temperature is
Gas flow rate, condenser temperature, etc. were adjusted. Aqueous t-butanol sodium amoxicillin slurry 8 was then injected through nozzle 6 into the drying chamber. The dry product and gas were sent from the bottom to a cyclone for separation. The experimental results are shown in the table below. From the results in the following table, it can be seen that spray drying of a slurry using an aqueous t-butanol solution exhibits excellent effects. The inlet temperature 7 is preferably about 180°C, and the outlet temperature 9 is preferably about 120°C.
The latter can be adjusted by cooling N 2 10. Also t
-Butanol The aqueous solution preferably contains about 1.5 parts of t-butanol per 3.6 parts of water.
【表】【table】
【表】
噴霧乾燥した固体ナトリウムアモキシシリンの
上記4バツチの純度と物理的性質はエチレンオキ
サイドによる様な殺菌後商業的使用に適してい
た。
乾燥機への供給液製造(上の溶解工程)におい
ては微粉末アモキシシリン3水化物(効力845mc
g/mgm)をアモキシシリン3水化物Kg当り水
2.4とt−ブタノール1.5を用いてt−ブタノ
ール水溶液中にスラリとし25℃に保つた。このス
ラリに1.97N水酸化ナトリウム水溶液を連続して
加え約2%過剰(1.23/Kg)とした。Table: The purity and physical properties of the four batches of spray-dried solid sodium amoxicillin were suitable for commercial use after sterilization, such as with ethylene oxide. In the production of the feed solution to the dryer (dissolution step above), finely powdered amoxicillin trihydrate (potency 845mc) was used.
g/mgm) of water per Kg of amoxicillin trihydrate
A slurry was prepared in an aqueous t-butanol solution using 2.4 parts of t-butanol and 1.5 parts of t-butanol, and the slurry was kept at 25°C. A 1.97N aqueous sodium hydroxide solution was continuously added to this slurry to give an approximately 2% excess (1.23/Kg).
【表】【table】
【表】【table】
【表】
噴霧乾燥工程における圧力は望む粒子大きさを
えるため変更した。
圧力ノズルを用いて無菌状態のもとにおける噴
霧乾燥操作は無菌固体ナトリウムアモキシシリン
を生成し、それは無菌状態のまま直接びんに充填
できる。
アモキシシリンの抗菌性質および臨床用法はそ
の3水化物の経口使用について医療文献によく知
られている。非経口投与についてはその水溶液を
注射するのが好ましいが、溶液は本発明の方法の
様に不溶性3水化物を水溶性の高いナトリウム塩
に転化する必要がある。ナトリウムアモキシシリ
ン水溶液の非経口投与の結果は例えばD.A.スパ
イカーらの“アモキシシリンの薬剤運動学:静脈
内、経口および筋肉内投与後の薬量依存関係”
(Antimicrobial Agents and Chemotherapy,
11,132(1977))およびS.A.ヒルらの“非経口投
与したアモキシシリンの薬剤運動学”(Journal
of Infection2,320〜332(1980))に記載されて
いる。Table: The pressure during the spray drying process was varied to obtain the desired particle size. A spray drying operation under aseptic conditions using a pressure nozzle produces sterile solid sodium amoxicillin, which can be directly filled into bottles under aseptic conditions. The antibacterial properties and clinical uses of amoxicillin are well known in the medical literature for the oral use of its trihydrate. For parenteral administration, it is preferred to inject the aqueous solution, which requires conversion of the insoluble trihydrate to the highly water-soluble sodium salt, as in the method of the present invention. The results of parenteral administration of sodium amoxicillin aqueous solutions can be found, for example, in DA Spiker et al.'s “Drug Kinetics of Amoxicillin: Dose-dependence after Intravenous, Oral and Intramuscular Administration”.
(Antimicrobial Agents and Chemotherapy,
11, 132 (1977)) and SA Hill et al., “Pharmacokinetics of parenterally administered amoxicillin” (Journal
of Infection 2, 320-332 (1980)).
第1図は本発明で用いる噴霧乾燥装置の一例を
示す概略図である。
FIG. 1 is a schematic diagram showing an example of a spray drying apparatus used in the present invention.
Claims (1)
シシリンスラリーを噴霧乾燥装置で噴霧乾燥する
ことを特徴とする固体ナトリウムアモキシシリン
の製法。 2 噴霧乾燥装置の入口温度を約180℃としかつ
出口温度を約120℃とする特許請求の範囲第1項
に記載の方法。 3 噴霧乾燥されるスラリーが水3.6毎に対し
t−ブタノール約1.5を含む特許請求の範囲第
1項に記載の方法。[Claims] 1. A method for producing solid sodium amoxicillin, which comprises spray-drying a slurry of sodium amoxicillin in an aqueous solution of t'-butanol in a spray dryer. 2. The method according to claim 1, wherein the inlet temperature of the spray drying device is about 180°C and the outlet temperature is about 120°C. 3. The method of claim 1, wherein the slurry to be spray dried comprises about 1.5 parts t-butanol to every 3.6 parts water.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8107247A FR2503710B1 (en) | 1981-04-10 | 1981-04-10 | PROCESS FOR PRODUCING SODIUM SALT OF AMOXICILLIN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57179191A JPS57179191A (en) | 1982-11-04 |
| JPH0219119B2 true JPH0219119B2 (en) | 1990-04-27 |
Family
ID=9257255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57057416A Granted JPS57179191A (en) | 1981-04-10 | 1982-04-08 | Manufacture of sodium amoxicillin |
Country Status (23)
| Country | Link |
|---|---|
| JP (1) | JPS57179191A (en) |
| KR (1) | KR880001410B1 (en) |
| AU (1) | AU559766B2 (en) |
| BE (1) | BE892451A (en) |
| CA (1) | CA1182108A (en) |
| CH (1) | CH651836A5 (en) |
| DE (1) | DE3213308A1 (en) |
| DK (1) | DK157382A (en) |
| ES (1) | ES511295A0 (en) |
| FI (1) | FI821247A7 (en) |
| FR (1) | FR2503710B1 (en) |
| GB (1) | GB2096599B (en) |
| GR (1) | GR76106B (en) |
| IE (1) | IE52939B1 (en) |
| IT (1) | IT1148165B (en) |
| LU (1) | LU84007A1 (en) |
| NL (1) | NL8201467A (en) |
| NO (1) | NO821174L (en) |
| NZ (1) | NZ200281A (en) |
| PT (1) | PT74727B (en) |
| SE (1) | SE8202269L (en) |
| YU (1) | YU43132B (en) |
| ZA (1) | ZA822400B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0131147B2 (en) * | 1983-06-10 | 1996-12-04 | Beecham Group p.l.c. | Crystalline amoxycillin salt |
| IT1255716B (en) * | 1992-10-05 | 1995-11-10 | PROCEDURE FOR THE PREPARATION OF STERILE BETA-LACTAMIC ANTIBIOTICS | |
| AT412213B (en) * | 2000-05-30 | 2004-11-25 | Sandoz Ag | METHOD FOR DRYING AMOXICILLIN OR AMOXICILLIN-CONTAINING, ORAL, SOLID PHARMACEUTICAL COMPOSITIONS USING A GAS WITH A DEFINED GAS HUMIDITY |
| CN105055169B (en) * | 2015-07-11 | 2019-01-22 | 鲁南制药集团股份有限公司 | A method of preparing Imipenem and Cilasatin Sodium aseptic powdery |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1471235A (en) * | 1974-09-18 | 1977-04-21 | Beecham Group Ltd | Amoxycillin derivatives |
| GB1527557A (en) * | 1976-07-07 | 1978-10-04 | Beecham Group Ltd | Process for preparing solid sodium amoxycillin |
| GB1576731A (en) * | 1976-08-10 | 1980-10-15 | Beecham Group Ltd | Process for the preparation of sodium amoxycillin |
| EP0012496B1 (en) * | 1978-12-08 | 1983-07-20 | Beecham Group Plc | A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof |
-
1981
- 1981-04-10 FR FR8107247A patent/FR2503710B1/en not_active Expired
-
1982
- 1982-02-12 AU AU80455/82A patent/AU559766B2/en not_active Expired
- 1982-02-16 GR GR67339A patent/GR76106B/el unknown
- 1982-02-26 YU YU432/82A patent/YU43132B/en unknown
- 1982-03-02 GB GB8206075A patent/GB2096599B/en not_active Expired
- 1982-03-10 BE BE0/207536A patent/BE892451A/en not_active IP Right Cessation
- 1982-03-12 LU LU84007A patent/LU84007A1/en unknown
- 1982-04-06 DK DK157382A patent/DK157382A/en not_active IP Right Cessation
- 1982-04-06 KR KR8201511A patent/KR880001410B1/en not_active Expired
- 1982-04-06 NO NO821174A patent/NO821174L/en unknown
- 1982-04-06 NL NL8201467A patent/NL8201467A/en not_active Application Discontinuation
- 1982-04-07 ES ES511295A patent/ES511295A0/en active Granted
- 1982-04-07 FI FI821247A patent/FI821247A7/en not_active Application Discontinuation
- 1982-04-07 ZA ZA822400A patent/ZA822400B/en unknown
- 1982-04-07 IT IT48188/82A patent/IT1148165B/en active
- 1982-04-08 IE IE844/82A patent/IE52939B1/en not_active IP Right Cessation
- 1982-04-08 JP JP57057416A patent/JPS57179191A/en active Granted
- 1982-04-08 CH CH2211/82A patent/CH651836A5/en not_active IP Right Cessation
- 1982-04-08 CA CA000400753A patent/CA1182108A/en not_active Expired
- 1982-04-08 PT PT74727A patent/PT74727B/en unknown
- 1982-04-08 DE DE19823213308 patent/DE3213308A1/en not_active Withdrawn
- 1982-04-08 NZ NZ200281A patent/NZ200281A/en unknown
- 1982-04-08 SE SE8202269A patent/SE8202269L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BE892451A (en) | 1982-09-10 |
| PT74727B (en) | 1985-01-08 |
| GB2096599B (en) | 1985-01-23 |
| YU43132B (en) | 1989-04-30 |
| AU559766B2 (en) | 1987-03-19 |
| KR830010116A (en) | 1983-12-26 |
| FI821247L (en) | 1982-10-11 |
| ZA822400B (en) | 1983-02-23 |
| FI821247A0 (en) | 1982-04-07 |
| GB2096599A (en) | 1982-10-20 |
| NO821174L (en) | 1982-10-11 |
| IE52939B1 (en) | 1988-04-13 |
| NZ200281A (en) | 1984-12-14 |
| CH651836A5 (en) | 1985-10-15 |
| PT74727A (en) | 1982-05-01 |
| DE3213308A1 (en) | 1982-11-11 |
| IT8248188A0 (en) | 1982-04-07 |
| IT1148165B (en) | 1986-11-26 |
| GR76106B (en) | 1984-08-03 |
| ES8304138A1 (en) | 1983-02-16 |
| ES511295A0 (en) | 1983-02-16 |
| FR2503710A1 (en) | 1982-10-15 |
| IE820844L (en) | 1983-10-10 |
| YU43282A (en) | 1985-06-30 |
| JPS57179191A (en) | 1982-11-04 |
| FR2503710B1 (en) | 1985-07-05 |
| CA1182108A (en) | 1985-02-05 |
| KR880001410B1 (en) | 1988-08-01 |
| LU84007A1 (en) | 1983-02-22 |
| NL8201467A (en) | 1982-11-01 |
| AU8045582A (en) | 1982-10-14 |
| DK157382A (en) | 1982-10-11 |
| FI821247A7 (en) | 1983-10-08 |
| SE8202269L (en) | 1982-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6857467B2 (en) | Methods for particle processing of active pharmaceutical ingredients | |
| Malik | Bacteriophage encapsulation using spray drying for phage therapy | |
| CA2543248C (en) | Process for making sterile aripiprazole of desired mean particle size | |
| EP1291014B1 (en) | A process for producing a pharmaceutical solid preparation containing a poorly soluble drug | |
| JPS61176521A (en) | Treatment of dosage form | |
| MX2012005224A (en) | Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof. | |
| JP2004532277A5 (en) | ||
| KR20050013548A (en) | Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process | |
| US3979520A (en) | Preparation of rapidly resorbable glibenclamide | |
| JPH0219119B2 (en) | ||
| JP2007525534A (en) | Powder composition of a sensitive active substance that is at least partially amorphous | |
| US5902844A (en) | Spray drying of pharmaceutical formulations containing amino acid-based materials | |
| JPH02357B2 (en) | ||
| CN102058548B (en) | Ambroxol hydrochloride composition for injection and preparation method thereof | |
| JP5607746B2 (en) | Method for producing solid gadobenate dimeglumine complex | |
| JPH02295926A (en) | Method and apparatus for preparing germ-free infusible powder of antibiotics | |
| JPS6287518A (en) | Simultaneous drying and granulating process for extracts obtained from deprotenized calf blood | |
| JPH09309834A (en) | Manufacturing method of efonidipine hydrochloride preparation | |
| Pisano et al. | Modernizing manufacturing of parenteral products: from batch to continuous lyophilization | |
| JPH04198137A (en) | Production of dried sterile sodium carbonate | |
| JP2001064189A (en) | Enteric lactic acid bacteria composition | |
| CN110237097A (en) | A kind of Fufang Anfenwanan capsules pellet and preparation method thereof | |
| CN108743548A (en) | A kind of Cefprozil granule and preparation method thereof | |
| CN120346153A (en) | Sustained-release oral preparation based on ground lactose and preparation method thereof | |
| JPH04210912A (en) | Solid porous dosage unit form containing beads and preparation thereof |